Datenbank ARAMIS

First in class therapeutic intervention in solid tumors: Development of YB-800R1, a radio labeled mAb targeting NPTXR



Gesamtkosten: CHF287,823.40

Beteiligte

  • PSI - Paul Scherrer Institut
  • PSI - Paul Scherrer Institut

Abstract

Key words

Abstract


https://www.sbfi.admin.ch/content/sbfi/en/home/research-and-innovation/research-and-innovation-in-switzerland/aramis/datenbank-aramis.publication-id-56825.html